Annabel Samimy's Stock Ratings

Stifel Analyst

Annabel Samimy is an analyst at Stifel. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/22/2024

Overall Average Return

34.0%

Smart Score

71.6%

Overall Average Return Percentile

89th

Number of Ratings

33
Buy NowGet Alert
07/03/2024KMDABuy Now
Kamada
$5.76212.5% → $18Initiates → BuyGet Alert
05/28/2024CALTBuy Now
Calliditas Therapeutics
$38.563.73%$55 → $40DowngradeBuy → HoldGet Alert
05/03/2024PHATBuy Now
Phathom Pharmaceuticals
$11.50108.7% → $24Initiates → BuyGet Alert
04/12/2024RGNXBuy Now
Regenxbio
$12.77213.23% → $40MaintainsBuyGet Alert
03/15/2024VKTXBuy Now
Viking Therapeutics
$51.5855.1% → $80ReiteratesBuy → BuyGet Alert
03/15/2024JAZZBuy Now
Jazz Pharmaceuticals
$109.70109.66%$225 → $230MaintainsBuyGet Alert
03/08/2024EOLSBuy Now
Evolus
$12.31103.09%$23 → $25ReiteratesBuy → BuyGet Alert
02/16/2024IVABuy Now
Inventiva
$2.60861.54%$27 → $25MaintainsBuyGet Alert
02/14/2024VKTXBuy Now
Viking Therapeutics
$51.58-32.14%$30 → $35MaintainsBuyGet Alert
11/01/2023RGNXBuy Now
Regenxbio
$12.77174.08% → $35Initiates → BuyGet Alert
10/05/2023OCSBuy Now
Oculis Holding
$12.58178.25% → $35Initiates → BuyGet Alert
08/29/2023APLSBuy Now
Apellis Pharmaceuticals
$37.0575.44%$60 → $65MaintainsBuyGet Alert
08/08/2023VKTXBuy Now
Viking Therapeutics
$51.58-41.84% → $30Reiterates → BuyGet Alert
07/28/2023RETABuy Now
Reata Pharmaceuticals
$110 → $172.5DowngradeBuy → HoldGet Alert
06/27/2023CARABuy Now
Cara Therapeutics
$0.377479.86% → $28ReiteratesBuy → BuyGet Alert
06/26/2023FGENBuy Now
FibroGen
$1.26773.02%$28 → $11DowngradeBuy → HoldGet Alert
06/02/2023FGENBuy Now
FibroGen
$1.26UpgradeHold → BuyGet Alert
05/16/2023VKTXBuy Now
Viking Therapeutics
$51.58-41.84%$25 → $30MaintainsBuyGet Alert
04/17/2023RXDXBuy Now
Prometheus Biosciences
$155 → $200DowngradeBuy → HoldGet Alert
04/13/2023RETABuy Now
Reata Pharmaceuticals
$105 → $115MaintainsBuyGet Alert
03/28/2023VKTXBuy Now
Viking Therapeutics
$51.58-51.53%$22 → $25MaintainsBuyGet Alert
03/17/2023IVABuy Now
Inventiva
$2.60938.46% → $27Initiates → BuyGet Alert
03/17/2023VKTXBuy Now
Viking Therapeutics
$51.58-57.35% → $22Initiates → BuyGet Alert
03/07/2023MLYSBuy Now
Mineralys Therapeutics
$13.75227.27% → $45Initiates → BuyGet Alert
02/21/2023APLSBuy Now
Apellis Pharmaceuticals
$37.05102.43%$65 → $75MaintainsBuyGet Alert
12/12/2022HZNPBuy Now
Horizon Therapeutics
$138 → $116.5DowngradeBuy → HoldGet Alert
11/10/2022CLSDBuy Now
Clearside Biomedical
$1.16589.66% → $8UpgradeHold → BuyGet Alert
11/01/2022RXDXBuy Now
Prometheus Biosciences
$50 → $55MaintainsBuyGet Alert
10/13/2022EVFMBuy Now
Evofem Biosciences
$0.013497.12%$375 → $62.5DowngradeBuy → HoldGet Alert
09/08/2022APLSBuy Now
Apellis Pharmaceuticals
$37.0575.44%$60 → $65MaintainsBuyGet Alert
09/08/2022ISEEBuy Now
IVERIC bio
$28 → $35MaintainsBuyGet Alert
08/23/2022AERIBuy Now
Aerie Pharmaceuticals
$27 → $15.25DowngradeBuy → HoldGet Alert
06/30/2022ANGNBuy Now
Angion Biomedica
$50 → $15DowngradeBuy → HoldGet Alert